GO:1905150 regulation of voltage-gated sodium channel activity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905150 describes any biological process that modulates the frequency, rate, or extent of voltage-gated sodium channel activity, a core determinant of membrane excitability.
• Voltage-gated sodium channel (Nav) regulation occurs at multiple levels, including transcriptional control by hormones and growth factors, post-translational modification, and auto-regulation of channel expression.
• Slow inactivation is a major intrinsic regulatory mechanism that shapes Nav channel availability and can be targeted by disease-modifying interventions.
• Nav channel subunits and regulatory proteins are implicated in cancer progression, pain, and neurological disorders, making them high-value research targets [3,5,7].
• Kinases such as AKT1 and inflammatory cytokines such as TNF-α can directly or indirectly regulate Nav channel function and expression [4,6].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of Nav regulatory networks in disease-relevant cell types.
Description
Regulation of voltage-gated sodium channel activity (GO:1905150) is a biological process that encompasses any mechanism controlling the frequency, rate, or extent of sodium flux through voltage-gated sodium channels. These channels are responsible for the rapid upstroke of the action potential in excitable cells, and their activity must be tightly regulated to maintain normal physiological signaling. Dysregulation of this process is increasingly recognized as a driver of pathologies ranging from cancer to chronic pain and neurological disease [1,7]. Understanding how Nav channels are regulated at the transcriptional, post-translational, and biophysical levels is therefore a central goal in molecular physiology and translational research [1,2]. This article integrates authoritative GO annotation with verified PubMed literature to provide a research-grade overview of GO:1905150, its molecular players, and the experimental strategies used to study it.
regulation of voltage-gated sodium channel activity At A Glance
| GO ID | GO:1905150 |
|---|---|
| GO term | regulation of voltage-gated sodium channel activity |
| Ontology | biological_process |
| Synonym | regulation of voltage-dependent sodium channel activity; regulation of voltage gated sodium channel activity; regulation of voltage-gated sodium ion channel activity; regulation of voltage-sensitive sodium channel |
| Major function | Modulates the frequency, rate, or extent of sodium ion flux through voltage-gated sodium channels, thereby controlling membrane excitability. |
| Key regulatory inputs | Hormones, growth factors, kinases (e.g., AKT1), cytokines (e.g., TNF-α), and channel auto-regulation [1,4,6]. |
| Biophysical mechanism | Includes slow inactivation gating that limits channel availability during sustained depolarization. |
| Disease relevance | Cancer, chronic pain, glioma, and neurological disorders [3,5,7]. |
| Experimental models | CRISPR knockout, point mutation, knock-in, overexpression, and pharmacological modulation. |
What Is GO:1905150?
GO:1905150, regulation of voltage-gated sodium channel activity, is defined as any process that modulates the frequency, rate, or extent of voltage-gated sodium channel activity. In practical terms, it includes mechanisms that alter the opening, closing, inactivation, or surface expression of Nav channels, thereby tuning the excitability of neurons, muscle cells, and other electrically active cell types.
Why Is regulation of voltage-gated sodium channel activity Important in Cell Biology?
Regulation of voltage-gated sodium channel activity is fundamental to excitable cell physiology because Nav channels initiate and propagate action potentials, and even small changes in their regulation can alter neuronal firing, cardiac rhythm, and muscle contraction. Beyond classical excitability, Nav channel regulation is now recognized as a driver of cancer cell motility, invasion, and proliferation, where hormones and growth factors can alter channel expression and function. The process is also a validated therapeutic axis: modulators of Nav channels are under development for pain management, and slow inactivation gating is a target for state-dependent drug action [2,7]. Consequently, understanding GO:1905150 is essential for researchers in neuroscience, oncology, cardiology, and drug discovery.
• Controls the initiation and propagation of action potentials in neurons, muscle, and cardiac cells.
• Dysregulated Nav channel expression and activity contribute to cancer progression and metastasis.
• Nav channel subunits such as β3 modulate glioma cell motility independently of channel activity, revealing non-canonical regulatory roles.
• Slow inactivation gating regulates channel availability and is a target for therapeutic modulation.
• Kinase signaling, including AKT1, directly regulates Nav1.1 function, linking growth factor pathways to excitability.
• Inflammatory cytokines such as TNF-α regulate Nav channels during viral latency, connecting neuroinflammation to excitability.
• Nav1.6 is a candidate therapeutic target in glioma, with small-molecule modulators under screening.
• Pharmacological modulation of Nav channels has analgesic potential for chronic pain.
• Auto-regulation of Nav channel expression provides a feedback mechanism that maintains excitability within homeostatic bounds.
• CRISPR-based models enable causal testing of Nav regulatory genes in disease-relevant contexts.
What Happens During regulation of voltage-gated sodium channel activity?
Transcriptional and Growth Factor Control of Nav Channel Expression
In simple terms: Cells can make more or fewer sodium channels by turning the corresponding genes on or off in response to signals.
Regulation of voltage-gated sodium channel activity begins with control of channel expression. Hormones and growth factors can alter the transcription of SCN genes, leading to changes in Nav channel density at the plasma membrane. This transcriptional regulation is often coupled to auto-regulatory feedback, where changes in channel activity themselves influence subsequent expression levels. In cancer cells, this growth factor-driven regulation can promote a more excitable phenotype that supports migration and invasion.
Post-Translational Modification and Kinase Signaling
In simple terms: After channels are made, enzymes can attach chemical tags that change how well the channels work.
Nav channel function is modulated by phosphorylation and other post-translational modifications. For example, the kinase AKT1 regulates the voltage-dependent sodium channel NaV1.1, altering its functional properties. Inflammatory signaling via TNF-α also regulates Nav channels during herpes simplex virus latency establishment, demonstrating that cytokines can tune channel activity in the nervous system. These modifications can change channel gating, trafficking, or stability, thereby adjusting excitability on short timescales.
Slow Inactivation Gating
In simple terms: Channels can enter a long-lasting closed state that prevents them from reopening for a while.
Slow inactivation is an intrinsic gating process that reduces Nav channel availability during sustained depolarization. Recent structural work has elucidated the mechanism of slow inactivation, revealing how conformational changes in the channel protein stabilize a non-conducting state. This process is a key determinant of the frequency and rate of sodium channel activity and is targeted by drugs that preferentially bind to inactivated states.
Modulation by Auxiliary Subunits
In simple terms: Helper proteins that stick to the main channel can change its behavior and its role in the cell.
Voltage-gated sodium channels are complexes of a pore-forming α subunit and auxiliary β subunits. The β3 subunit has been shown to modulate C6 glioma cell motility independently of channel activity, indicating that auxiliary subunits can regulate cellular behaviors through non-conducting functions. This expands the concept of Nav channel regulation beyond ion flux to include signaling and cell adhesion roles.
Convergence on Sodium Conductance as a Final Common Pathway
In simple terms: Many different signals all end up changing how much sodium flows into the cell.
Diverse regulatory inputs, including transcriptional, post-translational, and subunit-mediated mechanisms, converge on the overall sodium conductance of the membrane. This convergence allows cells to integrate multiple signals into a single excitability output. The concept of convergence on voltage-gated sodium conductance highlights why GO:1905150 is central to understanding membrane excitability in health and disease.
Key Genes Involved in GO:1905150 regulation of voltage-gated sodium channel activity
The following genes and proteins are experimentally implicated in the regulation of voltage-gated sodium channel activity, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN1A | Encodes NaV1.1 α subunit; regulated by AKT1 | Epilepsy, excitability disorders; kinase regulation |
| SCN8A | Encodes NaV1.6 α subunit; target in glioma | Glioma proliferation and candidate drug screening |
| SCN3B | Encodes β3 auxiliary subunit; modulates glioma motility | Non-canonical Nav subunit functions in cancer |
| AKT1 | Kinase that regulates NaV1.1 function | Growth factor signaling to excitability |
| TNF-α (TNF) | Cytokine that regulates Nav channels during HSV latency | Neuroinflammation and viral latency |
| Nav channel α subunits (general) | Pore-forming subunits; subject to hormone/growth factor regulation | Cancer excitability and auto-regulation |
| Nav channel β subunits (general) | Auxiliary subunits; modulate channel trafficking and signaling | Cell motility and adhesion |
| SCN5A | Cardiac Nav1.5 α subunit; regulation impacts arrhythmia | Cardiac excitability; not directly cited in verified list but part of Nav family |
| SCN9A | Nav1.7 α subunit; analgesic target | Pain management and channel modulators |
| SCN10A | Nav1.8 α subunit; analgesic target | Pain management and channel modulators |
| SCN11A | Nav1.9 α subunit; analgesic target | Pain management and channel modulators |
| FGF (growth factors) | Growth factors that regulate Nav expression | Cancer progression and channel auto-regulation |
| EGF (growth factors) | Growth factors that regulate Nav expression | Cancer progression and channel auto-regulation |
| Nav1.1 (protein) | Voltage-gated sodium channel regulated by AKT1 | Neuronal excitability and kinase signaling |
| Nav1.6 (protein) | Voltage-gated sodium channel in glioma | Glioma and drug screening |
| β3 subunit (protein) | Modulates glioma motility independently of channel activity | Cancer cell motility |
| TNF-α receptor signaling components | Mediate cytokine regulation of Nav channels | HSV latency and neuroinflammation |
How Is regulation of voltage-gated sodium channel activity Regulated?
Regulation of voltage-gated sodium channel activity is itself subject to multiple layers of control. Hormones and growth factors can alter SCN gene transcription, and auto-regulatory feedback loops adjust channel expression in response to changes in activity. Kinase signaling, exemplified by AKT1, directly modulates Nav1.1 function. Inflammatory cytokines such as TNF-α regulate Nav channels during herpes simplex virus latency establishment, linking immune signaling to excitability. At the biophysical level, slow inactivation provides an intrinsic regulatory mechanism that limits channel availability during sustained depolarization. Auxiliary subunits such as β3 can also modulate cellular behaviors independently of channel activity, adding a non-conducting layer of regulation. Together, these mechanisms ensure that sodium conductance is tuned to physiological demand and can be disrupted in disease.
regulation of voltage-gated sodium channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN8A | Glioma proliferation and drug response | Knockout or point-mutation glioma cell lines; overexpression for drug screening |
| SCN3B | Glioma cell motility | Knockout and overexpression in C6 glioma cells |
| SCN1A | Neurological excitability disorders via AKT1 regulation | Point-mutation knock-in of phosphorylation sites; AKT1 knockout |
| TNF-α signaling components | HSV latency and neuroinflammation | Knockout of TNF-α or its receptor in neuronal latency models |
| SCN9A/SCN10A/SCN11A | Chronic pain | Knockout and knock-in models for analgesic screening |
Cancer and Glioma
Voltage-gated sodium channels are increasingly recognized as contributors to cancer cell motility, invasion, and proliferation. Hormones and growth factors regulate Nav channel expression in cancer, and this regulation can promote a more aggressive phenotype. In glioma, Nav1.6 is a candidate therapeutic target, and small-molecule modulators are being screened for activity. The β3 subunit modulates C6 glioma cell motility independently of channel activity, suggesting that Nav subunits can influence cancer biology through non-conducting mechanisms.
Pain and Analgesia
Nav channels are validated targets for pain management. Modulators of voltage-gated sodium channels have analgesic potential, particularly for chronic pain conditions. Subtypes such as Nav1.7, Nav1.8, and Nav1.9 are under active investigation as analgesic targets, and regulation of their activity is central to pain signaling.
Neurological and Infectious Disease
Regulation of Nav channels by inflammatory cytokines such as TNF-α occurs during herpes simplex virus latency establishment, linking neuroinflammation to altered excitability. Kinase signaling via AKT1 regulates NaV1.1, and disruptions in this pathway may contribute to neurological disorders characterized by abnormal excitability. Slow inactivation gating defects can also underlie channelopathies, making this process relevant to epilepsy and other neurological conditions.
From regulation of voltage-gated sodium channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate Nav regulatory gene alter sodium current density? | CRISPR knockout cell line followed by patch-clamp electrophysiology |
| Does a specific phosphorylation site on a Nav channel control its gating? | Point-mutation knock-in of the phospho-null or phospho-mimetic residue |
| Does a disease-associated variant in a Nav regulatory gene change excitability? | Knock-in of the patient variant into an isogenic cell line |
| Where and when is a Nav regulatory protein expressed? | Tagged knock-in with fluorescent or epitope tag for imaging and proteomics |
| Does overexpression of a Nav subunit drive cancer cell motility? | Overexpression cell model with motility and invasion assays |
| Can a drug modulate Nav channel slow inactivation? | Cell line expressing wild-type or mutant Nav channels plus electrophysiology |
How to Study the regulation of voltage-gated sodium channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Sodium current density, activation, inactivation kinetics | Functional impact of regulatory genes or mutations [2,6] |
| RNA-seq / qPCR | SCN gene expression levels | Transcriptional regulation by hormones or growth factors |
| Western blot | Nav channel protein abundance | Validation of knockout or overexpression models |
| Mass spectrometry | Post-translational modifications and interactome | Kinase and cytokine signaling to Nav channels [4,6] |
| Live-cell imaging | Channel localization and trafficking | Tagged knock-in studies |
| Motility / invasion assays | Cell migration and invasion | Non-conducting Nav subunit functions in cancer |
| Drug screening assays | Modulation of channel activity or cell viability | Identification of Nav-targeting compounds [5,7] |
Electrophysiology
Patch-clamp electrophysiology is the gold-standard method for measuring voltage-gated sodium channel activity and its regulation. It can quantify current density, activation, inactivation, and recovery kinetics, allowing researchers to determine how a candidate regulatory gene or mutation affects channel function [2,6].
Transcriptional and Expression Analysis
RNA-seq and quantitative PCR can measure changes in SCN gene expression in response to hormones, growth factors, or genetic perturbations. These methods are useful for identifying auto-regulatory feedback and for validating CRISPR knockout or overexpression models.
Proteomics and Post-Translational Modification Mapping
Mass spectrometry-based proteomics can identify phosphorylation and other modifications on Nav channels and their regulatory proteins. This approach helps define how kinases such as AKT1 modify channel function and how cytokine signaling alters the Nav channel interactome.
Imaging and Motility Assays
Live-cell imaging and motility assays are used to study non-conducting functions of Nav subunits, such as the β3 subunit's effect on glioma cell motility. Fluorescently tagged knock-in models enable visualization of channel trafficking and localization in real time.
How CRISPR Can Be Used to Study GO:1905150 regulation of voltage-gated sodium channel activity
Knockout
CRISPR knockout of candidate Nav regulatory genes, such as SCN8A or SCN3B, allows researchers to determine whether the gene is necessary for normal sodium channel activity or cancer cell motility [3,5]. Knockout cell lines can be subjected to electrophysiology, motility assays, and drug screening to establish causal roles [3,5].
Point Mutation
Point-mutation models are used to dissect specific regulatory sites, such as phosphorylation residues targeted by AKT1 on NaV1.1. By introducing phospho-null or phospho-mimetic mutations, researchers can test how individual modifications affect channel gating and excitability.
Knock-in
Knock-in of disease-associated variants or tagged versions of Nav regulatory genes enables isogenic comparisons and real-time imaging. For example, tagging endogenous SCN3B can reveal its localization and interaction partners in glioma cells. Knock-in models are also valuable for studying slow inactivation gating mutants.
Overexpression
Overexpression of Nav subunits or regulatory proteins, such as β3, can drive phenotypic changes like increased cell motility. Overexpression models are useful for gain-of-function studies and for screening drugs that target Nav channel activity [5,7].
How EDITGENE Supports regulation of voltage-gated sodium channel activity Research
Researchers studying regulation of voltage-gated sodium channel activity-related genes often need to determine whether a candidate gene is causally involved in channel function, excitability, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to enable these investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of voltage-gated sodium channel activity research.
Frequently Asked Questions About regulation of voltage-gated sodium channel activity
What is GO:1905150 regulation of voltage-gated sodium channel activity?
GO:1905150 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of voltage-gated sodium channel activity.
What genes are involved in regulation of voltage-gated sodium channel activity?
Key genes include SCN1A, SCN8A, SCN3B, AKT1, and TNF, which encode Nav channel subunits or regulatory proteins [3,4,5,6].
How do growth factors regulate voltage-gated sodium channels?
Growth factors and hormones can alter SCN gene transcription and channel expression, often through auto-regulatory feedback loops.
What is slow inactivation of voltage-gated sodium channels?
Slow inactivation is a gating process that reduces channel availability during sustained depolarization, and its structural mechanism has been recently elucidated.
Can voltage-gated sodium channels be targeted for pain relief?
Yes, modulators of voltage-gated sodium channels have analgesic potential for chronic pain management.
How does AKT1 regulate sodium channels?
AKT1 is a kinase that regulates the voltage-dependent sodium channel NaV1.1, altering its functional properties.
What role do Nav channels play in cancer?
Nav channels can promote cancer cell motility and invasion, and their expression is regulated by hormones and growth factors.
How does TNF-α affect sodium channels?
TNF-α regulates voltage-gated sodium channels during herpes simplex virus latency establishment, linking inflammation to excitability.
What is the β3 subunit's role in glioma?
The β3 subunit modulates C6 glioma cell motility independently of channel activity, indicating non-conducting functions.
How can CRISPR help study sodium channel regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of Nav regulatory genes in disease-relevant cells [3,5,6].
Conclusion
GO:1905150 regulation of voltage-gated sodium channel activity is a central biological process that integrates transcriptional, post-translational, and biophysical mechanisms to control membrane excitability. Its dysregulation is implicated in cancer, pain, and neurological disorders, making it a high-priority research area [1,3,5,7]. Advances in structural biology and CRISPR-based models are accelerating the discovery of new regulatory mechanisms and therapeutic targets [2,3,6]. Researchers can leverage EDITGENE's comprehensive cell model services to dissect these pathways with precision.
References
- 1. Fraser SP et al.. 2014. Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.. Philos Trans R Soc Lond B Biol Sci 369(1638):20130105 PMID: 24493753
- 2. Chen H et al.. 2024. Structural mechanism of voltage-gated sodium channel slow inactivation.. Nat Commun 15(1):3691 PMID: 38693179
- 3. Liu H et al.. 2025. The voltage-gated sodium channel β3 subunit modulates C6 glioma cell motility independently of channel activity.. Biochim Biophys Acta Mol Basis Dis 1871(6):167844 PMID: 40245999
- 4. Zhang Q et al.. 2024. Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment.. J Neurovirol 30(5-6):513-523 PMID: 39367281
- 5. Ai Y et al.. 2023. Role of the voltage‑gated sodium channel Nav1.6 in glioma and candidate drugs screening.. Int J Mol Med 51(6) PMID: 37052249
- 6. Arribas-Blázquez M et al.. 2021. Regulation of the voltage-dependent sodium channel Na(V)1.1 by AKT1.. Neuropharmacology 197:108745 PMID: 34375627
- 7. McDougall JJ et al.. 2024. Analgesic potential of voltage gated sodium channel modulators for the management of pain.. Curr Opin Pharmacol 75:102433 PMID: 38277942
- 8. Lin WH et al.. 2015. Regulation of membrane excitability: a convergence on voltage-gated sodium conductance.. Mol Neurobiol 51(1):57-67 PMID: 24677068
